57/100BElevance Health company profile
- CEO
- Gail Koziara Boudreaux
- Employees
- 96,615
- Headquarters
- 220 Virginia Avenue, Indianapolis, IN 46204, US
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- IPO date
- 30 Oct 2001
- Stock exchange
- NYSE
- ISIN
- US0367521038
Website:elevancehealth.com
About the company
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Employees
Elevance Health had about 97,100 employees at the end of fiscal year 2025 (31 December 2025), by its annual report. That is 6.8% fewer than a year before.
Employees at each fiscal year end, as the company reports them in its annual report (10-K); revenue and net income per employee are the fiscal year's over that count.
Who owns Elevance Health
Institutions such as funds, banks and insurers held 92.4% of Elevance Health's shares on 30 June 2026, 1,681 of them reporting holdings to the SEC; the rest is held by individual investors and other shareholders.
Shares free to trade
Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.
How Elevance Health pays its executives
The chief executive was paid 8.92M USD for fiscal 2005, 40% of it in shares and options.
| Name and position | Salary | Bonus | Stock awards | Option awards | Other pay | Total pay |
|---|---|---|---|---|---|---|
| Larry C. Glasscock Chairman of the Board, President and Chief Executive Officer | 1.25M USD | 3.43M USD | 3.17M USD | 400.00K USD | 671.58K USD | 8.92M USD |
| David C. Colby Executive Vice President and Chief Financial Officer | 666.10K USD | 1.24M USD | 1.03M USD | 130.00K USD | 587.27K USD | 3.66M USD |
| Keith R. Faller President and CEO Central Region and Corporate Executive Vice President | 650.00K USD | 1.38M USD | 1.03M USD | 130.00K USD | 231.89K USD | 3.43M USD |
| Joan E. Herman President and CEO Specialty, Senior and State Sponsored Business and Corporate Executive Vice President | 573.02K USD | 978.94K USD | 792.00K USD | 212.19K USD | 143.77K USD | 2.70M USD |
| John S. Watts, Jr. President and CEO National Accounts Strategic Business Unit and Corporate Executive Vice President | 555.67K USD | 966.91K USD | 792.00K USD | 100.00K USD | 129.52K USD | 2.54M USD |
FY2005 · From the company's proxy statements to the SEC: what each named executive was paid for the fiscal year, shares and options at their value when granted. The latest filing
Common questions about Elevance Health
Source: Financial Modeling Prep